StevenT.HarrisMDF.A.C.P.

PubMed

• 17 citations
  History of etidronate
  Nelson B. Watts, Charles H. Chesnut, Harry K. Genant, Steven T. Harris, Rebecca D. Jackson
  Bone. 2020-05-01
• 10 citations
  Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for Osteoporosis.
  E. Michael Lewiecki, David L. Kendler, K. Shawn Davison, David A. Hanley, Steven T. Harris
  The American Journal of Medicine. 2019-05-29
• 12 citations
  Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis
  E. Michael Lewiecki, John P. Bilezikian, John J. Carey, Richard M. Dell, Catherine M. Gordon
  Journal of Clinical Densitometry. 2018-01-01

Journal Articles

• Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosis  
  EM Lewiecki, PD Miller, ST Harris, DC Bauer, KS Davison, L Dian, DA Hanley, MR McClung, CK Yuen, DL Kendler, J Clin Densitom.;17(4):490-5. doi: 10.1016/j.jocd.2013.09.018. Epub 2013 Oct 25, 2014
• Longterm fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies  
  PD Miller, RR Recker, S Harris, S Silverman, D Felsenberg, J Reginster, BM Day, C Barr, D Masanauskaite, Osteoporos.Int.;25(1):349-57, 2014
• Bone mineral density in patients with alopecia areata treated with long-term intralesional corticosteroids  
  A Samrao, JM Fu, ST Harris, VH Price, J.Drugs Dermatol.;12(2):e36-40, 2013
• Medicines and bone loss  
  J Bollerslev, ST Harris, BZ Leder, J.Clin.Endocrinol.Metab.;98(4):33A-4A, 2013
• Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosis  
  EM Lewiecki, PD Miller, ST Harris, DC Bauer, KS Davison, L Dian, DA Hanley, MR McClung, CK Yuen, DL Kendler, J Clin Densitom. pii: S1094-6950(13)00180-7. doi: 10.1016/j.jocd.2013.09.018. [Epub ahead of print 2, 2013
• Hypoparathyroidism.  
  J Bollerslev, ST Harris, BZ Leder, J.Clin.Endocrinol.Metab.;98(6):39A-40A, 2013
• Glucocorticoid-induced osteoporosis  
  J Bollerslev, ST Harris, BZ Leder, J.Clin.Endocrinol.Metab.; 97(2):35A, 2012
• Two-year efficacy and tolerability of risedronate 35 mg once a week for the treatment of women with postmenopausal osteoporosis  
  ST Harris, NB Watts, Z Li, AA Chines, DA Hanley, JP Brown, Curr.Med.Res.Opin. 20(5):757-764, 2004
• Osteoporosis in men: epidemiology, diagnosis, prevention and treatment - a review of the evidence  
  WP Olszynski, KS Davison, JD Adachi, JP Brown, SR Cummings, DA Hanley, ST Harris, AB Hodsman, D Kendler, MR McClung, PD Miller, CK Yuen, Clin.Ther. 26(1):15-28, 2004
• In vivo assessment of architecture and micro-finite element analysis derived indices of mechanical properties of trabecular bone in the radius  
  DC Newitt, S Majumdar, B Van Rietbergen, G von Ingersleben, ST Harris, HK Genant, C Chesnut, P Garnero, B MacDonald, Osteoporos.Int. 13:6-17, 2002
• Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty  
  NB Watts, ST Harris, HK Genant, Osteoporos.Int. 12:429-437, 2001
• Bisphosphonates for the treatment of postmenopausal osteoporosis: clinical studies of etidronate and alendronate  
  ST Harris, Osteoporos Int. Suppl. 3:S11-S16, 2001
• Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women  
  ST Harris, EF Eriksen, M Davidson, MP Ettinger, AH Moffett Jr, DJ Baylink, CE Crusan, AA Chines, J.Clin.Endocrinol.Metab. 86:1890-1897, 2001
• A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures Study  
  CH Chesnut III, S Silverman, K Andriano, H Genant, A Gimona, S Harris, D Kiel, M LeBoff, M Maricic, P Miller, C Moniz, M Peacock, P Richardson, N Watts, D Baylink, Am.J.Med. 109:267-276, 2000
• Assessment of vertebral bone mineral density using volumetric quantitative CT  
  TF Lang, J Li, ST Harris, HK Genant, J.Comput.Assist.Tomogr. 23:130-137, 1999
• Factors affecting broadband ultrasound attenuation results of the calcaneus using a gel-coupled quantitative ultrasound scanning system  
  S Cheng, B Fan, L Wang, T Fuerst, M Lian, C Njeh, Y He, M Kern, M Lappin, F Tylavsky, D Casal, S Harris, HK Genant, Osteoporos.Int. 10:495-504, 1999
• The effect of risedronate treatment on vertebral and non-vertebral fractures in women with postmenopausal osteoporosis: a double-blind, randomized, placebo-controlled ...  
  ST Harris, NB Watts, HK Genant, CD McKeever, T Hangartner, M Keller, CH Chesnut III, J Brown, EF Eriksen, MS Hoseyni, DW Axelrod, PD Miller, JAMA 282:1344- 1352, 1999
• Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: A randomized, controlled clinical trial  
  R Lindsay, F Cosman, RA Lobo, BW Walsh, ST Harris, JE Reagan, CL Liss, ME Melton, CA Byrnes, J.Clin.Endocrinol.Metab. 84:3076-3081, 1999
• Calcitonin treatment for central giant cell granulomas of the mandible: report of two cases  
  MA Pogrel, JA Regezi, ST Harris, SR Goldring, J.Oral Maxillofac.Surg. 57:848-853, 1999
• Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment  
  PD Miller, NB Watts, AA Licata, ST Harris, HK Genant, RD Wasnich, PD Ross, RD Jackson, MS Hoseyni, SL Schoenfeld, DJ Valent, CH Chesnut III, Am.J.Med. 103:468-476, 1997
• Prevention of nonvertebral fractures by alendronate. A meta-analysis  
  DB Karpf, DR Shapiro, E Seeman, KE Ensrud, CC Johnston Jr, S Adami, ST Harris, AC Santora II, LJ Hirsch, L Oppenheimer, D Thompson, JAMA 277:1159- 1164, 1997
• Dose-response relationships for alendronate treatment in osteoporotic elderly women  
  HG Bone, RW Downs Jr, JR Tucci, ST Harris, RS Weinstein, AA Licata, MR McClung, DB Kimmel, BJ Gertz, E Hale, WJ Polvino, J.Clin.Endocrinol.Metab. 82:265-274, 1997
• Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal w...  
  JL Stock, NH Bell, CH Chesnut III, KE Ensrud, HK Genant, ST Harris, MR McClung, FR Singer, RA Yood, S Pryor- Tillotson, L Wei, AC Santora II, Am.J.Med. 103:291-297, 1997
• Noninvasive assessment of bone mineral and structure: State of the art  
  HK Genant, K Engelke, T Fuerst, CC Glüer, S Grampp, ST Harris, M Jergas, T Lang, Y Lu, S Majumdar, A Mathur, M Takada, J.Bone Miner.Res. 11:707-730, 1996
• Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling  
  CH Chesnut III, MR McClung, KE Ensrud, NH Bell, HK Genant, ST Harris, FR Singer, JL Stock, RL Yood, PD Delmas, U Kher, S Pryor-Tillotson, AC Santora II, Am.J.Med. 99:144-152, 1995
• Join now to see all

Lectures

• Optimizing Fracture Protection 
  The Woodlands, TX - 2015
• Optimizing Fracture Protection 
  Williamsburg, VA - 2015
• Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis 
  San Francisco - 2015
• Optimizing Fracture Protection 
  Miramar, FL - 2015
• Optimizing Fracture Protection 
  Myrtle Beach, SC - 2015
• Optimizing Fracture Protection 
  San Diego, CA - 2015
• Optimizing Fracture Protection 
  Camdenton, MO - 2015
• Update in Hypoparathyroidism 
  Atlanta, GA - 2014
• HIV and Bone Health 
  California Pacific Medical Center - 2014
• Optimizing Fracture Protection 
  Stateline, NV - 2014
• Optimizing Fracture Protection 
  Overland Park, KS - 2014
• Optimizing Fracture Protection 
  Miramar, FL - 2014
• Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis 
  San Francisco - 2014
• New…Therapies for Osteoporosis 
  Atlanta, GA - 2014
• Update in Hypoparathyroidism 
  Charlotte, NC - 2014
• Update in Hypoparathyroidism 
  Manhattan Beach, CA - 2014
• New…Therapies for Osteoporosis 
  Charlotte, NC - 2014
• New…Therapies for Osteoporosis 
  Manhattan Beach, CA - 2014
• Controversies in Osteoporosis Therapy 
  San Francisco, CA - 2013
• Optimizing Fracture Protection 
  Ridgedale, MO - 2013
• Optimizing Fracture Protection 
  Atlanta, GA - 2013
• Osteoporosis Diagnosis and Treatment 
  Phoenix, AZ - 2013
• Optimizing Fracture Protection 
  Albuquerque, NM - 2013
• Osteoporosis Diagnosis and Treatment 
  New York, NY - 2013
• Osteoporosis Diagnosis and Treatment 
  Minneapolis, MN - 2013
• Join now to see all